Epidermal growth factor ointment
Term · Oncology and biomedicine · MLC-T-ONC-013384
A topical ointment containing a recombinant form of human epidermal growth factor (EGF) with potential protective activity against EGF receptor (EGFR/HER1) inhibitor-induced cutaneous toxicities. Upon topical application of the EGF ointment, EGF locally activates EGFR, thereby abrogating EGFR inhibition in the skin caused by systemic EGFR inhibiting agents. This may help inhibit the skin rash induced by EGFR antagonists. EGFR, a tyrosine kinase, plays a key role in maintaining epidermal integrity.
| Identifier | MLC-T-ONC-013384 |
|---|---|
| Field | Oncology and biomedicine |
| Synonyms | EGF ointment; sesal yeongo |
| References | National Cancer Institute Thesaurus (CC BY 4.0) |
Record as JSON
{
"id": "MLC-T-ONC-013384",
"term": "Epidermal growth factor ointment",
"field": "Oncology and biomedicine",
"definition": "A topical ointment containing a recombinant form of human epidermal growth factor (EGF) with potential protective activity against EGF receptor (EGFR/HER1) inhibitor-induced cutaneous toxicities. Upon topical application of the EGF ointment, EGF locally activates EGFR, thereby abrogating EGFR inhibition in the skin caused by systemic EGFR inhibiting agents. This may help inhibit the skin rash induced by EGFR antagonists. EGFR, a tyrosine kinase, plays a key role in maintaining epidermal integrity.",
"synonyms": [
"EGF ointment",
"sesal yeongo"
],
"references": [
"National Cancer Institute Thesaurus"
],
"url": "https://mlchart.com/terminology/oncology/epidermal-growth-factor-ointment/"
}
Record 6,756 of 17,717 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.